Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919000 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
Acute bowel toxicity after WPRT Tomotherapy is mild, relatively rare and associated to larger CTVN and older age. While efforts to further reduce it do not appear to be relevant, the pre-treatment assessment of “high-risk” patients may help physicians in better managing symptoms. A prospective validation would be very important in confirming these results and in better refining dose-volume bowel effects including symptoms milder that the ones here investigated and retrospectively assessed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Barbara Longobardi, Genoveffa Berardi, Claudio Fiorino, Filippo Alongi, Cesare Cozzarini, Aniko Deli, Mariangela La Macchia, Lucia Perna, Nadia Gisella Di Muzio, Riccardo Calandrino,